PubRank

Vincent C Emery

Author PubWeight™ 44.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic content of wild-type human cytomegalovirus. J Gen Virol 2004 3.58
2 Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 2004 2.54
3 Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 2011 2.50
4 The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013 2.28
5 Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS 2009 1.87
6 Two novel spliced genes in human cytomegalovirus. J Gen Virol 2003 1.87
7 Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009 1.64
8 Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J Gen Virol 2010 1.51
9 Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. J Gen Virol 2003 1.13
10 The ESCRT machinery is not required for human cytomegalovirus envelopment. Cell Microbiol 2007 1.13
11 Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes 2004 1.09
12 The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS 2009 1.09
13 Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation. Transplantation 2011 1.06
14 Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy. J Clin Virol 2010 1.05
15 Genotypic analysis of two hypervariable human cytomegalovirus genes. J Med Virol 2008 1.04
16 Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus. J Med Virol 2004 1.02
17 Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. J Allergy Clin Immunol 2011 1.00
18 Cytomegalovirus quantification: where to next in optimising patient management? J Clin Virol 2011 0.95
19 A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. J Infect Dis 2004 0.94
20 Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control. Xenotransplantation 2003 0.94
21 Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. AIDS 2002 0.93
22 Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation. Liver Transpl 2007 0.93
23 Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. Lancet 2002 0.93
24 Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis. Proc Biol Sci 2006 0.90
25 Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase. J Antimicrob Chemother 2002 0.88
26 Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency. J Allergy Clin Immunol 2012 0.87
27 The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein. Herpesviridae 2010 0.86
28 Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants. J Virol 2012 0.85
29 Detection of cytomegalovirus in human placental cells by polymerase chain reaction. APMIS 2006 0.84
30 Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. Semin Hematol 2003 0.82
31 Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. J Med Virol 2003 0.81
32 Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation. Transplantation 2007 0.80
33 Taming the transplantation troll by targeting terminase. N Engl J Med 2014 0.79
34 Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and long-term graft function. J Med Virol 2010 0.78
35 Susceptibility of porcine cytomegalovirus to antiviral drugs. J Antimicrob Chemother 2004 0.77
36 The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J Infect Dis 2002 0.77
37 Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease. J Infect Dis 2002 0.77
38 Clinical xenotransplantation. Lancet 2003 0.75
39 The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response. J Med Virol 2004 0.75
40 Could a vaccine against immune-evading cytomegalovirus become a reality? Expert Rev Vaccines 2011 0.75
41 [Drugs against human cytomegalovirus]. Pol Merkur Lekarski 2002 0.75
42 Sequence flexibility of the immunodominant HLA A*0201 restricted ppUL83 CD8 T-cell epitope of human cytomegalovirus. J Med Virol 2010 0.75
43 Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy. PLoS One 2017 0.75